AdEPT
 
Aldata Solution
 
Castify
 
CMT Medical
 
Comet
 
Cosmo Bioscience
 
Cosmo Pharmaceuticals
 
Cyberguard
 
Datamars
 
HITC
 
Home Director
 
LZ Medien Holding
 
MCN Telecom
 
Medialine
 
MediCentrix
 
Micrus Endovascular
 
Myriad
 
Net263
 
Netviewer
 
Plus Orthopedics
 
Publity
 
Secure Computing
 
Thommen Medical
 
Trados
 
Valista / iPin
 
Vanguard
 
Virtual Radiologic
 
Wavelight
 
Webwasher
 
Xelector
 

INVISION III

Cosmo Pharmaceuticals   Leinate, Italy Year of investment: 2005 www.cosmopharmaceuticals.com

Cosmo is an emerging fully-integrated speciality pharmaceutical company that aims to become a global leader in the market of optimised therapies for selected gastro-intestinal diseases. The company’s proprietary clinical development pipeline specifically addresses innovative treatments for Inflammatory Bowel Diseases (IBD), such as Ulcerative Colitis and Crohn’s Disease, as well as for colon infections.